자동 면역측정 분석기 시장 보고서(2026년)
Automated Immunoassay Analyzers Global Market Report 2026
상품코드 : 1939309
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,629,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,583,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,536,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

자동 면역측정 분석기 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 230억 9,000만 달러에서 2026년에는 263억 9,000만 달러로, CAGR 14.3%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 집중형 임상검사실 확대, 일상적인 면역측정 검사량 증가, 질병 스크리닝 프로그램 확대, 검사 워크플로우의 조기 자동화, 감염성 질환 모니터링의 면역측정 시스템 도입 등이 주요 요인으로 꼽히고 있습니다.

자동 면역측정 분석기 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 449억 3,000만 달러에 달하며, CAGR은 14.2%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 만성질환 및 내분비 질환 검사 수요 증가, 종양학 및 바이오마커 검사 확대, 신속한 진단 결과 제공에 대한 수요, 실험실 자동화 플랫폼 통합 촉진, 제약 및 바이오테크놀러지 분야의 R&D 검사 용도 확대 등이 꼽힙니다. 예측 기간 중 주요 동향으로는 고처리량 진단 검사에 대한 수요 증가, 감염 및 내분비학 검사에 대한 채용 증가, 연구 및 학술연구소의 자동화 검사 확대, 치료제 모니터링 및 종양학 진단에 대한 사용 증가, 검사 효율성 향상을 위한 검사실 워크플로우의 표준화 등이 있습니다.

병원 수 증가는 향후 자동 면역측정 장치 시장의 성장을 가속할 것으로 예측됩니다. 병원은 전문적인 인프라와 의료 전문가가 상주하며 일상적인 치료와 응급처치가 필요한 환자에게 의료, 수술, 진단 서비스를 제공하는 의료기관입니다. 전 세계 병원 수 증가는 인구의 확대 및 고령화에 따른 의료 수요 증가와 의료 인프라에 대한 투자 확대에 의해 추진되고 있습니다. 자동면역측정장치는 다양한 질환에 대한 높은 처리량으로 정확하고 신속한 진단 검사를 가능하게 하여 임상 효율성과 환자 치료 결과를 향상시켜 병원을 지원합니다. 예를 들어 미국 비영리단체인 미국 의료협회(American Health Care Association)에 따르면 2023년 5월 기준 미국의 병원 수는 2022년 6,093개에서 2023년 6,129개로 증가하여 0.59%의 성장률을 보일 것으로 예상하고 있습니다. 따라서 병원 수 증가가 자동 면역측정 장치 시장의 성장을 주도하고 있습니다.

자동 면역측정기 시장의 주요 기업은 경쟁 우위를 확보하기 위해 소형 면역측정기 등 첨단 제품 개발에 주력하고 있습니다. 이 소형 장비는 생물학적 검체에서 특정 바이오마커를 검출하는 면역측정 검사를 수행하도록 설계되었으며, 특히 공간과 이동성에 제약이 있는 다양한 의료 현장에서 편리성과 효율성을 제공합니다. 예를 들어 2023년 7월 독일에 본사를 둔 의료 기업 지멘스 헬시니어스는 '아테리카 CI 분석기'를 발표했습니다. 이 컴팩트한 시스템은 면역측정과 임상화학 검사를 단일 플랫폼에 통합하여 다기능적이고 효율적인 검사 솔루션에 대한 수요 증가에 대응합니다. 아테리카 CI 분석기는 랜덤 액세스 샘플링, 미량 흡입, 자동화된 유지보수 및 품질관리 스케줄링 기능을 갖추고 있으며, 시료 처리 시간의 일관성과 예측 가능성을 높입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Automated immunoassay analyzers are sophisticated laboratory instruments designed to conduct immunoassays with minimal human input. These analyzers automate the detection and measurement of specific proteins, hormones, and other substances in biological samples, enhancing accuracy and efficiency in diagnostic testing. They are commonly used in clinical laboratories for disease diagnosis, monitoring, and research purposes.

The primary types of automated immunoassay analyzers include immunofluorescence, chemiluminescence, enzyme-linked immunosorbent assay (ELISA), multiplexed assay systems, and radioimmunoassay. Immunofluorescence is a technique that employs fluorescent-labeled antibodies to identify specific antigens in biological samples. These analyzers are applied in various fields, including infectious diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing. They are utilized by hospitals, diagnostic laboratories, research and academic institutions, as well as pharmaceutical and biotechnology companies.

Tariffs are influencing the automated immunoassay analyzers market by increasing costs for precision optical components, electronic modules, assay reagents, and instrument assemblies sourced across cross-border manufacturing networks. The impact is most significant in chemiluminescence and multiplexed assay systems, as well as analyzer production activities concentrated in Asia-Pacific and parts of Europe where component imports are tariff-sensitive. Hospitals, diagnostic laboratories, and pharmaceutical and biotechnology company end-user segments are facing higher procurement and installation costs due to elevated instrument pricing. However, tariffs are also encouraging regional assembly, localized reagent manufacturing, and strategic supplier diversification, which may strengthen supply resilience and stimulate domestic production capacity over time.

The automated immunoassay analyzers market research report is one of a series of new reports from The Business Research Company that provides automated immunoassay analyzers market statistics, including automated immunoassay analyzers industry global market size, regional shares, competitors with a automated immunoassay analyzers market share, detailed automated immunoassay analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated immunoassay analyzers industry. This automated immunoassay analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated immunoassay analyzers market size has grown rapidly in recent years. It will grow from $23.09 billion in 2025 to $26.39 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of centralized clinical laboratories, growth in routine immunoassay testing volumes, increasing disease screening programs, early automation of laboratory workflows, adoption of immunoassay systems for infectious disease monitoring.

The automated immunoassay analyzers market size is expected to see rapid growth in the next few years. It will grow to $44.93 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising chronic and endocrine disorder testing needs, growing oncology and biomarker testing, demand for faster turnaround diagnostic results, increasing integration of automated platforms in research labs, expansion of pharmaceutical and biotech r&d testing applications. Major trends in the forecast period include growing demand for high-throughput diagnostic testing, increased adoption in infectious disease and endocrinology testing, expansion of automated testing in research and academic laboratories, rising utilization in therapeutic drug monitoring and oncology diagnostics, standardization of laboratory workflows to improve testing efficiency.

The increasing number of hospitals is expected to propel the growth of the automated immunoassay analyzers market going forward. Hospitals are healthcare institutions that provide medical, surgical, and diagnostic services to patients requiring routine treatment or emergency care, supported by specialized infrastructure and healthcare professionals. The global rise in the number of hospitals is driven by growing healthcare demand from expanding and aging populations, along with increased investments in healthcare infrastructure. Automated immunoassay analyzers support hospitals by enabling high-throughput, accurate, and rapid diagnostic testing for a wide range of diseases, improving clinical efficiency and patient outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the United States increased to 6,129 in 2023 from 6,093 in 2022, reflecting a 0.59% growth. Therefore, the increasing number of hospitals is driving the growth of the automated immunoassay analyzers market.

Leading companies in the automated immunoassay analyzer market are focusing on developing advanced products, such as compact immunoassay analyzers, to gain a competitive edge. These compact devices are designed for conducting immunoassay tests to detect specific biomarkers in biological samples and offer convenience and efficiency in various healthcare settings, especially where space and mobility are constraints. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer. This compact system combines immunoassay and clinical chemistry testing into a single platform, addressing the growing demand for versatile and efficient testing solutions. The Atellica CI Analyzer features random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling to enhance the consistency and predictability of sample processing times.

In July 2024, Roche, a Switzerland-based provider of diagnostics, pharmaceutical products, and point-of-care testing solutions, acquired LumiraDx's point-of-care technology for an undisclosed amount. With this acquisition, Roche aims to strengthen and decentralize its diagnostics portfolio by integrating a multi-assay point-of-care platform that combines immunoassay and clinical chemistry testing on a single system. This move supports Roche's strategic objective to expand access to rapid, near-patient diagnostics, particularly in primary care and low-resource settings. LumiraDx is a UK-based developer of a multi-assay point-of-care platform designed to deliver laboratory-quality results across immunoassay and clinical chemistry tests at the point of care.

Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd

North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated immunoassay analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The automated immunoassay analyzers market consists of sales of sample handlers, reagents, incubation chambers, thermal printers, and wash stations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automated Immunoassay Analyzers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses automated immunoassay analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for automated immunoassay analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated immunoassay analyzers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Automated Immunoassay Analyzers Market Characteristics

3. Automated Immunoassay Analyzers Market Supply Chain Analysis

4. Global Automated Immunoassay Analyzers Market Trends And Strategies

5. Automated Immunoassay Analyzers Market Analysis Of End Use Industries

6. Automated Immunoassay Analyzers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Automated Immunoassay Analyzers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Automated Immunoassay Analyzers Total Addressable Market (TAM) Analysis for the Market

9. Automated Immunoassay Analyzers Market Segmentation

10. Automated Immunoassay Analyzers Market Regional And Country Analysis

11. Asia-Pacific Automated Immunoassay Analyzers Market

12. China Automated Immunoassay Analyzers Market

13. India Automated Immunoassay Analyzers Market

14. Japan Automated Immunoassay Analyzers Market

15. Australia Automated Immunoassay Analyzers Market

16. Indonesia Automated Immunoassay Analyzers Market

17. South Korea Automated Immunoassay Analyzers Market

18. Taiwan Automated Immunoassay Analyzers Market

19. South East Asia Automated Immunoassay Analyzers Market

20. Western Europe Automated Immunoassay Analyzers Market

21. UK Automated Immunoassay Analyzers Market

22. Germany Automated Immunoassay Analyzers Market

23. France Automated Immunoassay Analyzers Market

24. Italy Automated Immunoassay Analyzers Market

25. Spain Automated Immunoassay Analyzers Market

26. Eastern Europe Automated Immunoassay Analyzers Market

27. Russia Automated Immunoassay Analyzers Market

28. North America Automated Immunoassay Analyzers Market

29. USA Automated Immunoassay Analyzers Market

30. Canada Automated Immunoassay Analyzers Market

31. South America Automated Immunoassay Analyzers Market

32. Brazil Automated Immunoassay Analyzers Market

33. Middle East Automated Immunoassay Analyzers Market

34. Africa Automated Immunoassay Analyzers Market

35. Automated Immunoassay Analyzers Market Regulatory and Investment Landscape

36. Automated Immunoassay Analyzers Market Competitive Landscape And Company Profiles

37. Automated Immunoassay Analyzers Market Other Major And Innovative Companies

38. Global Automated Immunoassay Analyzers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Automated Immunoassay Analyzers Market

40. Automated Immunoassay Analyzers Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기